Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.50M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$5.6M$11.3M2025 · bought $0 · sold $11.3M20252026 · bought $0 · sold $735K2026
Total +$0.0000 bought · $12.00M sold

All filings on record

Every Form 4 transaction we track for this filer

GHExercise
2026-06-17 · Guardant Health, Inc.
5,092
BMRNGrant
2026-06-02 · BIOMARIN PHARMACEUTICAL INC
7,490
KYTXGrant
2026-05-27 · Kyverna Therapeutics, Inc.
5,093
GHSell
2026-05-20 · Guardant Health, Inc.
$735.0K
OLMASell
2025-12-19 · Olema Pharmaceuticals, Inc.
$1.28M
OLMASell
2025-12-19 · Olema Pharmaceuticals, Inc.
$5.74M
OLMASell
2025-12-19 · Olema Pharmaceuticals, Inc.
$862.1K
OLMAExercise
2025-12-19 · Olema Pharmaceuticals, Inc.
$49.2K
OLMAExercise
2025-12-19 · Olema Pharmaceuticals, Inc.
$168.7K
OLMAExercise
2025-12-19 · Olema Pharmaceuticals, Inc.
$77.7K
OLMAExercise
2025-12-19 · Olema Pharmaceuticals, Inc.
$923.9K
GHSell
2025-12-05 · Guardant Health, Inc.
$367.4K
GHSell
2025-12-05 · Guardant Health, Inc.
$1.83M
GHSell
2025-12-05 · Guardant Health, Inc.
$870.0K
GHExercise
2025-12-05 · Guardant Health, Inc.
$340.8K
GHExercise
2025-12-05 · Guardant Health, Inc.
$334.6K
GHExercise
2025-12-05 · Guardant Health, Inc.
$349.8K
BMRNGrant
2025-08-01 · BIOMARIN PHARMACEUTICAL INC
7,000
GDRXExercise
2025-07-08 · GoodRx Holdings, Inc.
$81.8K
GHSell
2025-06-17 · Guardant Health, Inc.
$322.8K
GHExercise
2025-06-12 · Guardant Health, Inc.
8,088
GDRXGrant
2025-06-03 · GoodRx Holdings, Inc.
57,050
KYTXGrant
2025-05-29 · Kyverna Therapeutics, Inc.
16,634

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.